Dallas-based Tenet Healthcare added two independent directors to its board of directors: John P. Byrnes and Peter M. Wilver. Mr. Byrnes is the former chairman and CEO of Lincare Holdings, based in Chicago. Mr. Wilver serves as the executive vice president and chief administrative officer of Waltham, Mass.-based Thermo Fisher Scientific.
Analysts gave Tenet Healthcare shares a $32 price target. Based on 11 stock opinions, Tenet’s rating score is currently 1.93.
In the third quarter this year, Nashville, Tenn.-based AmSurg’s net revenue reached $822.2 million for the quarter, a 26 percent increase from Q3 FY 2015.
San Francisco-based Wells Fargo & Co. upgraded AmSurg shares from a “market perform” rating to an “outperform” rating. AmSurg’s market cap. is $3.45 billion.
Headquartered in Houston, Nobilis Health had $19.6 million in total cash as well as $86.2 million in accounts receivable and $23.8 million in total debt as of Sept. 30, 2016.
During the week of Oct. 31 to Nov. 1, Nashville-based Hospital Corporation of America shares plummeted 2.6 percent, trading at $75.33 per share.
If you have a question, issue or note to suggest on an ASC management and development company please contact Mary Rechtoris at mrechtoris@beckershealthcare.com.
More articles on surgery centers:
Nobilis’ Q3 revenue rallies 34.7%, losses total $2.8M — 13 key points
Montecito Medical Real Estate to acquire neurology & orthopedic-focused ASC
Tenet adds 2 independent directors: 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.